Who has been buying Celltrion Pharmaceutical stock?

0 distinct insiders have filed 0 disclosed insider purchases in Celltrion Pharmaceutical (068760), most recently on 2026-03-24. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Celltrion Pharmaceutical have?

Celltrion Pharmaceutical has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-02-21 to 2026-03-24.

Where does StockDrifts get Celltrion Pharmaceutical insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Celltrion Pharmaceutical 068760

Company

셀트리온제약Celltrion Pharmaceutical

Insiders

Buys

Total Value

—

Avg Return

—

Last Filing

2026-03-24

Celltrion Pharmaceutical (068760) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Celltrion Pharmaceutical is dated 2024-02-21; the most recent is 2026-03-24. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-03-24	BUY	PROGRAM	김주범 Kim Joo-beom	Managing Director	45	₩59,000	-2.2%	₩3M ($2K)
2026-03-24	BUY	PROGRAM	최덕규 Deokgyu Choi	Managing Director	165	₩59,000	-2.2%	₩10M ($7K)
2026-03-24	BUY	PROGRAM	이언형 Eonhyung Lee	moving	191	₩59,000	-2.2%	₩11M ($8K)
2026-03-24	BUY	PROGRAM	최승재 Seungjae Choi	Senior Vice President	105	₩59,000	-2.2%	₩6M ($4K)
2026-03-24	BUY	PROGRAM	유영호 Youngho Yoo	president	117	₩59,000	-2.2%	₩7M ($5K)
2026-03-24	BUY	PROGRAM	양지석 Yang Ji-seok	Managing Director	114	₩59,000	-2.2%	₩7M ($5K)
2026-03-24	BUY	PROGRAM	김승환 Seunghwan Kim	moving	8	₩59,000	-2.2%	₩472K ($328)
2026-03-24	BUY	주식배당	셀트리온 Celltrion	-	478.7K	₩59,000	-2.2%	₩28.2B ($19.6M)
2026-02-14	SELL	임원퇴임	우영제 Wooyoungje	moving	-6.1K	-	-	-
2026-01-29	BUY	주식매수선택권	김주범 Kim Joo-beom	Managing Director	762	₩74,100	-1.6%	₩56M ($39K)
2025-04-29	BUY	기타	최덕규 Deokgyu Choi	Managing Director	127	₩47,804	+52.5%	₩6M ($4K)
2025-04-29	BUY	기타	최덕규 Deokgyu Choi	Managing Director	24	₩47,804	+52.5%	₩1M ($797)
2025-04-29	BUY	주식매수선택권	최덕규 Deokgyu Choi	Managing Director	4.5K	₩47,804	+52.5%	₩215M ($149K)
2025-03-25	BUY	PROGRAM	최승재 Seungjae Choi	vice president	251	₩51,580	+41.3%	₩13M ($9K)
2025-03-25	BUY	PROGRAM	김주범 Kim Joo-beom	Managing Director	109	₩51,580	+41.3%	₩6M ($4K)
2025-03-25	BUY	PROGRAM	양지석 Yang Ji-seok	Managing Director	273	₩51,580	+41.3%	₩14M ($10K)
2025-03-25	BUY	PROGRAM	김승환 Seunghwan Kim	moving	20	₩51,580	+41.3%	₩1M ($716)
2025-03-25	BUY	PROGRAM	김태곤 Kim Tae-gon	moving	1	₩51,580	+41.3%	₩52K ($36)
2025-03-25	BUY	PROGRAM	서준영 Seo Jun-young	moving	2	₩51,580	+41.3%	₩103K ($72)
2025-03-25	BUY	PROGRAM	유영호 Youngho Yoo	president	279	₩51,580	+41.3%	₩14M ($10K)
2025-03-25	BUY	PROGRAM	이언형 Eonhyung Lee	moving	456	₩51,580	+41.3%	₩24M ($16K)
2025-03-25	BUY	PROGRAM	우영제 Wooyoungje	moving	288	₩51,580	+41.3%	₩15M ($10K)
2025-03-25	BUY	PROGRAM	최덕규 Deokgyu Choi	Managing Director	173	₩51,580	+41.3%	₩9M ($6K)
2025-01-01	SELL	임원퇴임	김중철 Kim Joong-cheol	moving	-1.2K	₩53,737	-35.7%	₩64M ($45K)
2025-01-01	BUY	신규선임	김승환 Seunghwan Kim	moving	400	₩53,737	+35.7%	₩21M ($15K)
2024-12-24	SELL	증여	이언형 Eonhyung Lee	moving	-1.6K	₩58,318	-25.0%	₩93M ($65K)
2024-10-30	BUY	주식매수선택권	양지석 Yang Ji-seok	Managing Director	999	₩57,944	+25.8%	₩58M ($40K)
2024-10-30	BUY	주식매수선택권	김주범 Kim Joo-beom	moving	727	₩57,944	+25.8%	₩42M ($29K)
2024-07-05	BUY	기타	유영호 Youngho Yoo	president	720	₩87,384	-16.6%	₩63M ($44K)
2024-04-30	BUY	주식매수선택권	우영제 Wooyoungje	moving	1.5K	₩89,814	-18.8%	₩133M ($93K)
2024-04-25	BUY	PROGRAM	서준영 Seo Jun-young	moving	15	₩84,767	-14.0%	₩1M ($883)
2024-03-26	BUY	PROGRAM	이언형 Eonhyung Lee	moving	511	₩105,328	-30.8%	₩54M ($37K)
2024-03-26	BUY	PROGRAM	우영제 Wooyoungje	moving	204	₩105,328	-30.8%	₩21M ($15K)
2024-03-26	BUY	주식배당	셀트리온 Celltrion	-	1.1M	₩105,328	-30.8%	₩114.3B ($79.4M)
2024-03-26	BUY	PROGRAM	양지석 Yang Ji-seok	Managing Director	212	₩105,328	-30.8%	₩22M ($16K)
2024-03-26	BUY	PROGRAM	김중철 Kim Joong-cheol	moving	41	₩105,328	-30.8%	₩4M ($3K)
2024-03-26	BUY	PROGRAM	김주범 Kim Joo-beom	moving	69	₩105,328	-30.8%	₩7M ($5K)
2024-03-26	BUY	PROGRAM	유영호 Youngho Yoo	president	231	₩105,328	-30.8%	₩24M ($17K)
2024-03-26	BUY	PROGRAM	최덕규 Deokgyu Choi	Managing Director	164	₩105,328	-30.8%	₩17M ($12K)
2024-03-26	BUY	PROGRAM	최승재 Seungjae Choi	vice president	239	₩105,328	-30.8%	₩25M ($17K)
2024-03-26	BUY	PROGRAM	김태곤 Kim Tae-gon	moving	1	₩105,328	-30.8%	₩105K ($73)
2024-02-29	BUY	기타	김중철 Kim Joong-cheol	moving	317	₩103,645	-29.7%	₩33M ($23K)
2024-02-21	BUY	증여취소	최승재 Seungjae Choi	vice president	3.5K	₩93,459	-22.0%	₩327M ($227K)
2024-02-21	BUY	기타	최승재 Seungjae Choi	vice president	6.5K	₩93,459	-22.0%	₩607M ($422K)
2024-02-21	SELL	기타	최승재 Seungjae Choi	vice president	-3.5K	₩93,459	+22.0%	₩327M ($227K)
2024-02-21	SELL	증여	최승재 Seungjae Choi	vice president	-6.5K	₩93,459	+22.0%	₩607M ($422K)

Frequently asked questions

Who has been buying Celltrion Pharmaceutical stock?: 0 distinct insiders have filed 0 disclosed insider purchases in Celltrion Pharmaceutical (068760), most recently on 2026-03-24. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Celltrion Pharmaceutical have?: Celltrion Pharmaceutical has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-02-21 to 2026-03-24.
Where does StockDrifts get Celltrion Pharmaceutical insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Celltrion Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.